Malar Mounds and Festoons: The Under-Eye Bulge That Filler and Eyelid Surgery Make Worse

There is a specific kind of under-eye complaint that arrives in consults already misdiagnosed, usually by the patient and sometimes by the practice. The patient points at a fullness that sits below the lower lid, out on the cheekbone, and calls it a bag. It is worse in the morning. It is worse after a salty dinner, after wine, after a bad night, after a flight. Some days it is barely there and some days it changes the shape of the face.

Under-eye bags do not behave that way. Herniated orbital fat is a structural finding, and structural findings do not fluctuate with a plane ticket. What the patient is describing is a malar mound, or in its more advanced form a festoon, and it is a fluid problem sitting in a tethered anatomic compartment. That distinction decides which procedure helps, which does nothing, and which makes the situation meaningfully worse for months.

The bulge below the bag is not the bag

The short answer: a malar mound is a triangular fullness over the cheekbone below the lower eyelid, a festoon is the more advanced version in which lax muscle and skin hang in visible folds, and neither is caused by the orbital fat that lower blepharoplasty removes.

The anatomy is worth a paragraph because it explains everything downstream. The soft tissue of the lower lid and upper cheek is not one continuous sheet. It is partitioned by retaining ligaments and septa that tether skin and muscle down to the bone of the orbital rim and the cheekbone. Anatomic studies of the region describe a malar septum running from the orbital rim out toward the skin, and the space it encloses is where fluid collects and cannot easily leave. Above that compartment sits the orbicularis retaining ligament, the structure that creates the visible groove separating lid from cheek. Below it sits the zygomatic ligamentous attachment, which creates the lower border of the mound. The mound is bounded on both sides by tissue that is anchored down, so anything that pools inside it stays inside it.

A festoon is the same territory with worse tissue quality. The orbicularis oculi muscle and the skin over it have lost tone, the compartment stretches, and instead of a firm triangular fullness the patient gets a hanging cascade of loose tissue that can extend well down the cheek. Chronic sun damage, smoking, age, thyroid disease, allergic disease, and repeated swelling all push a mound toward becoming a festoon.

Three things live in the same square inch of face and get called by each other's names constantly. The tear trough is a hollow. The under-eye bag is protruding orbital fat behind a weakening septum, which is the finding that lower eyelid surgery is actually designed to address. The malar mound is a fluid compartment sitting lower and more laterally than either one. A consult that does not name which of the three it is treating is not a plan.

Why it swells overnight and after a salty dinner

The short answer: the malar compartment has poor lymphatic drainage by design, so fluid enters it easily and leaves it slowly, and that is why the finding fluctuates on a schedule no fat pad ever would.

The lymphatic channels serving the lower lid and midface have to cross the same tethered zone that creates the mound. Drainage in that region is limited and easily disrupted. Lie flat for eight hours and gravity stops helping. Add sodium, alcohol, a poor night of sleep, seasonal allergies, or a viral illness and the compartment fills. Stand up, move around for a few hours, and it partially empties. Patients describe this as unpredictable. It is not unpredictable at all, and a good history extracts the pattern in about ninety seconds.

That pattern is also a diagnostic tool, and it costs nothing to use. Ask a patient to photograph the area within ten minutes of waking and again at six in the evening on the same day, in the same light, without makeup. Herniated fat looks the same in both frames. A malar mound often does not. Any practice proposing a surgical solution to something that halves in size by dinnertime should be asked to explain what exactly the operation is removing.

Systemic causes deserve a real look before any aesthetic plan, because a meaningful subset of persistent periorbital swelling belongs to medicine rather than surgery. Thyroid eye disease, kidney and cardiac conditions that cause fluid retention, chronic allergic disease, and untreated obstructive sleep apnea all present with facial edema that no amount of cosmetic work will resolve. This is the least glamorous part of the workup and the part most often skipped.

"

An under-eye bag looks the same at seven in the morning and seven at night. A malar mound does not. If the fullness has a schedule, it is fluid, and fluid does not respond to the operations designed for fat.

"

Filler is the most common way to make this worse

The short answer: hyaluronic acid is hydrophilic and the malar compartment already drains poorly, so filler placed in or near it can produce malar edema that persists for months and occasionally longer.

This is the single most consequential error in the region, and it happens because the patient asks for something reasonable. They want the hollow under the eye softened. Hyaluronic acid goes in. In some patients the result is exactly what everyone hoped for. In others, the product either sits in the wrong plane, migrates laterally into the malar space, or simply obstructs a drainage pathway that had no margin to spare, and the patient develops a persistent puffy fullness that is worse than what they came in with.

Two properties of the material drive this. Hyaluronic acid binds water, so the visible volume is not only the gel injected but the fluid it recruits. And filler does not always stay where it was placed, a behavior we covered in detail in our reporting on where filler actually goes after injection. In a compartment with limited outflow, a small amount of product in a slightly wrong plane produces a disproportionate and durable result.

Two practical facts belong in every under-eye filler consult. The first is that most hyaluronic acid used in the infraorbital region for the past decade and a half was used off-label, with products approved for other areas of the face, until a product carried a specific approval for the infraorbital hollow in recent years. Off-label use by a qualified physician is legal and routine across medicine, but a patient is entitled to know when it is happening. The second is that the remedy, hyaluronidase, is itself used off-label for this purpose. It is an enzyme approved by the FDA to disperse injected fluids and improve absorption of other drugs, and its use to dissolve hyaluronic acid filler is a repurposing that works well and is not always complete. Dissolving can flatten a malar mound caused by filler. It can also leave residual edema, and it cannot restore a lymphatic pathway that scarred.

Why eyelid surgery does not fix it, and sometimes worsens it

The short answer: lower blepharoplasty addresses fat and skin at and above the orbital rim, while the malar mound sits below the rim, so a technically successful operation can leave the bulge untouched or make it briefly more obvious.

This is the disappointment that generates second opinions. A patient with both findings has surgery, the bags are genuinely gone, the lid looks smoother, and the mound is still sitting on the cheekbone with nothing above it to disguise it. In some cases removing the fat above actually accentuates the fullness below by removing the transition that softened it. The operation did what it was designed to do. It was aimed at the wrong compartment.

There is also a real risk of temporary worsening. Surgery in the periorbital area disrupts lymphatic channels that were already marginal, and postoperative malar edema after lower lid work is common and can take many months to settle. That is a normal part of the swelling timeline after facial surgery, but patients who were never warned interpret it as a failed result at week six. Over-resection carries its own separate penalty: taking too much lower lid fat or skin can produce a hollowed, aged lid and, in the worst cases, lid malposition that pulls the lower lid away from the eye. Professional societies in oculoplastic and facial plastic surgery have spent two decades moving the field toward repositioning and preserving tissue rather than removing it, and the malar mound is one of the reasons why.

What actually helps, and how thin the evidence is

The short answer: several treatments have reported success in case series, none has been established by a large randomized trial, and any consult that presents a guaranteed fix for festoons is describing a confidence the literature does not support.

The honest state of the evidence is that this is a low-quality-evidence corner of aesthetic surgery. What exists is largely retrospective case series and expert technique papers in journals such as Plastic and Reconstructive Surgery and Aesthetic Surgery Journal, with small numbers, non-standardized grading of severity, short follow-up, and outcomes judged by the surgeon who performed the operation. That does not make the techniques worthless. It does mean the confidence intervals in the room should be wider than they usually are.

The approaches in current use, roughly in order of how invasive they are:

• Treating the systemic drivers first. Sodium, alcohol, sleep position, allergic disease, thyroid status, and sleep-disordered breathing. Costs nothing, resolves a fraction of cases outright, and clarifies what is left to treat.
• Dissolving prior filler. If the mound appeared or worsened after injections, hyaluronidase is the first move, and it is diagnostic as well as therapeutic.
• Sclerotherapy of the festoon. Case series in the oculoplastic literature describe injecting a sclerosing agent such as doxycycline into the festoon to obliterate the fluid space. Reported results are encouraging in selected patients, with swelling and discomfort after treatment and repeat sessions often required.
• Energy-based skin tightening and resurfacing. Fractional and ablative laser treatment can improve mild mounds by tightening the skin envelope. It does not address the underlying compartment, and results in this specific area are modest.
• Direct excision. Cutting the festoon out is the most reliable way to remove the tissue and the most likely to leave a visible scar on the cheek. It is a genuine tradeoff, not a technicality, and it belongs in the conversation only when the deformity is severe.
• Midface and orbicularis suspension procedures. Deeper approaches that release the retaining ligaments and resuspend the muscle and midface. More invasive, more variable, and highly dependent on the surgeon's experience with the specific technique.

The pattern across all six is the same. Mild mounds respond partially to conservative measures. Severe festoons respond meaningfully only to procedures that carry real costs. There is no option in this list that is both minor and reliable, which is precisely why the region attracts confident marketing.

The honest summary

The fullness on the cheekbone and the bag under the lid are two different diagnoses that happen to sit half an inch apart. One is fat behind a weakened septum. The other is fluid trapped in a compartment that drains poorly by anatomic design. They are treated by different procedures, and the standard treatment for one has no useful effect on the other.

That matters most because the default first move in aesthetics, hyaluronic acid filler, is the move most likely to worsen a malar mound. The material attracts water, the compartment cannot clear it, and the resulting edema can outlast the patient's patience by a wide margin. Dissolving usually helps. It does not always finish the job.

So take the two photographs, morning and evening, before you book anything. Ask whether you are being treated for a hollow, for herniated fat, or for a mound, and require that the answer use all three terms. Rule out the medical causes of facial swelling before accepting a surgical explanation. And when a practice offers a straightforward fix for festoons, ask what evidence supports it, because the published answer is a set of small case series and the correct posture toward it is interest rather than confidence. The patients who do best in this region are the ones whose surgeons were willing to say, out loud, which part of the problem they could not fix.